Diabetisk retinopati

Translated title of the contribution: Diabetic retinopathy

Jakob Grauslund*, Nis Andersen, Jens Andresen, Toke Bek, Sara Brandi, Javad Nouri Hajari, Søren Tang Knudsen, Caroline Schmidt Laugesen, Majbrit Lind, Mette Slot Nielsen, Katja Schielke, Yousif Subhi

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.
Translated title of the contributionDiabetic retinopathy
Original languageDanish
Article numberV04240246
JournalUgeskrift for Læger
Volume187
Issue number2
ISSN0041-5782
DOIs
Publication statusPublished - 20. Jan 2025

Fingerprint

Dive into the research topics of 'Diabetic retinopathy'. Together they form a unique fingerprint.

Cite this